Inozyme Pharma (INZY)
(Delayed Data from NSDQ)
$4.82 USD
+0.13 (2.77%)
Updated May 31, 2024 04:00 PM ET
After-Market: $4.82 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.37 | 2.32% |
Earnings Summary
For their last quarter, Inozyme Pharma (INZY) reported earnings of -$0.38 per share, missing the Zacks Consensus Estimate of -$0.35 per share. This reflects a negative earnings surprise of 8.57%. Look out for INZY's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.37 per share, reflecting a year-over-year decrease of 5.71%.
Earnings History
Price & Consensus
Zacks News for INZY
Why Earnings Season Could Be Great for Inozyme (INZY)
INZY: What are Zacks experts saying now?
Zacks Private Portfolio Services